STEPHENS KRISTIN (Chief Development Officer) exercised options at SYROS PHARMACEUTICALS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 11/4/2024ACC: 0000950170-24-120863
Officer· Chief Development Officer
Since Jun 2021
-6.10K
Net shares
Net seller
$12.8K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
17K acquired · 23.10K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+17K
Price / share
—
Trade value
—
% of position
67.4%
10/31/2024
25.24K→42.24K
Common Stock
Direct
Shares
−6.10K
Price / share
$2.09
Trade value
$12.76K
% of position
14.5%
10/31/2024
42.24K→36.13K
Total
Net shares
+10.90K
Net value
-$12.76K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/31/2024 | M · Option Exercise | +17K | — | — | 67.4% | 25.24K | 42.24K |
| Common Stock Direct | 10/31/2024 | F · Tax Withholding | −6.10K | $2.09 | $12.76K | 14.5% | 42.24K | 36.13K |
| Total | +10.90K | -$12.76K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
17K shares
Shares
−17K
Strike price
Held after
0.00
Exercisable
—
10/31/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock17K shares | 10/31/2024 | M · Option Exercise | −17K | — | 0.00 |